Evidence map›Paper›PMID 40593219›Full record

ReviewResults and problems in cell differentiation2025

Bromodomain and PHD Finger-Containing Protein 1: From Functions to a Developmental Disorder, Cancer, and Therapeutics.

Arezousadat Razavi, Paulina Varela-Castillo, Xiang-Jiao Yang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Results and problems in cell differentiation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arezousadat RazaviRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada. arezousadat.razavi@mail.mcgill.ca.
Paulina Varela-CastilloRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Xiang-Jiao YangRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada. xiang-jiao.yang@mcgill.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bromodomain and PHD finger-containing protein 1 (BRPF1) is an essential epigenetic regulator and plays a key role in post-translational modification of histones. It is a chromatin reader that recognizes acetylated histones and interacts with the paralogous lysine acetyltransferases KAT6A and KAT6B to promote histone acetylation and related acylations, such as propionylation, at lysine 23 of histone H3, thereby influencing gene expression and regulating developmental programs. BRPF1 contributes to a variety of cellular processes such as cell cycle progression, cell proliferation, cell differentiation, and responses to cellular stresses, including DNA damage. Moreover, BRPF1 is implicated in hematopoiesis, embryonic development, skeletal development, neurodevelopment, neurogenesis, learning, and memory. BRPF1 gene knockout in mice leads to severe bone marrow failure, anemia, and eventual death in a few weeks after birth. This review provides a brief overview of BRPF1 and its contribution to the molecular structure and biological functions of KAT6A and KAT6B complexes. We will explore the emerging evidence linking BRPF1 dysfunction to human diseases, particularly cancer and abnormal neurodevelopment, to highlight promising therapeutic opportunities for treating associated pathology.

Indexed as

Adaptor Proteins, Signal TransducingDevelopmental DisabilitiesNeoplasmsNuclear ProteinsAnimalsBromodomain Containing ProteinsDNA-Binding ProteinsHistone AcetyltransferasesHumansAdaptor Proteins, Signal TransducingBromodomain Containing ProteinsBRPF1 protein, humanDNA-Binding ProteinsHistone AcetyltransferasesKAT6A protein, humanNuclear ProteinsAcylationCancerClinVar variantGermline mutationHistone acetylationNeurodevelopmental disorderSomatic mutation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.